Venus Concept Inc. (NASDAQ:VERO) Short Interest Update

Venus Concept Inc. (NASDAQ:VERO) was the target of a large decrease in short interest during the month of September. As of September 15th, there was short interest totalling 3,800 shares, a decrease of 71.0% from the August 31st total of 13,100 shares. Based on an average daily trading volume, of 744,100 shares, the short-interest ratio is currently 0.0 days. Currently, 0.1% of the shares of the company are sold short.

Venus Concept Stock Performance

Shares of Venus Concept stock traded up $0.02 on Friday, hitting $0.61. The stock had a trading volume of 14,946,769 shares, compared to its average volume of 1,021,510. The stock has a market cap of $4.39 million, a price-to-earnings ratio of -0.09 and a beta of 0.51. The business’s 50 day moving average is $0.61 and its two-hundred day moving average is $0.67. The company has a quick ratio of 1.30, a current ratio of 1.99 and a debt-to-equity ratio of 9.72. Venus Concept has a twelve month low of $0.42 and a twelve month high of $2.43.

Venus Concept (NASDAQ:VERO) last posted its quarterly earnings data on Tuesday, August 13th. The company reported ($1.39) earnings per share for the quarter. The business had revenue of $16.58 million during the quarter. Analysts forecast that Venus Concept will post -6.37 EPS for the current year.

Hedge Funds Weigh In On Venus Concept

An institutional investor recently raised its position in Venus Concept stock. Masters Capital Management LLC lifted its holdings in shares of Venus Concept Inc. (NASDAQ:VERO) by 100.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 666,702 shares of the company’s stock after purchasing an additional 333,366 shares during the quarter. Masters Capital Management LLC owned 10.49% of Venus Concept worth $522,000 as of its most recent SEC filing. 87.41% of the stock is owned by hedge funds and other institutional investors.

About Venus Concept

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.